International Journal of

Blood Research and DisordersISSN: 2469-5696

Archive

 Open Access DOI:10.23937/2469-5696/1410003

Lenalidomide as a Steroid Sparing Agent in a Myelodysplastic Syndrome Patient with Refractory Sweet Syndrome

Chakra P Chaulagain and Kenneth B Miller

Article Type: Case Report | First Published: December 22, 2014

Malignancy associated Sweet syndrome (acute febrile neutrophilic dermatosis) accounts for approximately 20% of all cases of Sweet syndrome and is characterized by painful, erythematous inflammatory papules and nodules that can precede, coincide or follow malignancies with predilection for hematologic malignancies. Corticosteroids are the cornerstone of treatment with exquisite response which has made many clinicians to include steroid responsiveness as one of the diagnostic criteria. However, re...

 Open Access DOI:10.23937/2469-5696/1410002

Pharmacological Treatment may Impair Mineral Status in Blood

Joanna Suliburska

Article Type: Editorial | First Published: July 31, 2014

Some medicines may interact with mineral, with the result that changes occur in the concentration of minerals and other blood parameters that are associated with mineral status. Interpretation of the results of morphological and biochemical blood analyses therefore needs to take into account the drugs used by patients....

 Open Access DOI:10.23937/2469-5696/1410001

The Progress of Oncolytic Reovirus in Hematologic Malignancies: Can we Combat Blood Cancer with the Cold?

Jun Gong

Article Type: Editorial | First Published: July 30, 2014

Oncolytic reovirus continues to pick up momentum as a novel agent in the treatment of cancer. Since the initial discovery of the virus' tendency to preferentially replicate in transformed cell lines from studies in the late 1970s, reovirus has rapidly progressed from preclinical to clinical trials evaluating its efficacy across a spectrum of malignancies, including hematologic....

Volume 1
Issue 1